Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic – Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…
Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer’s – Novo Nordisk (NYSE:NVO)
Upcoming data from Novo Nordisk A/S (NYSE:NVO) early next month could offer the clearest signal yet on whether…
Novo Nordisk’s $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker – Novo Nordisk (NYSE:NVO)
In a presentation at the American Heart Association’s (AHA’s) 2025 Scientific Sessions, researchers on Tuesday shared data from…
Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets – Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY)
The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
What’s Going On With Novo Nordisk Stock Monday? – Novo Nordisk (NYSE:NVO)
The U.S. Food and Drug Administration (FDA) has identified repeated quality control failures, including foreign particle contamination, inadequate…
UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio? – Novo Nordisk (NYSE:NVO), UnitedHealth Group (NYSE:UNH)
Two healthcare giants, UnitedHealth Group Inc UNH and Novo Nordisk A/S NVO, are duking it out in very…
UnitedHealth’s Meta Moment? Bleeding Out Or Just A Bad X-Ray? – UnitedHealth Group (NYSE:UNH)
UnitedHealth Group Inc. UNH is enduring one of the most brutal drawdowns in its history—down 22% in a…
Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off – Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY)
The Bristol Myers Squibb Co. BMY and Pfizer Inc. PFE alliance announced a new direct-to-patient option for purchasing Eliquis (apixaban) via…